Minzhi Lv

机构：Fudan University, Fudan University Shanghai Cancer Center, Zhongshan Hospital, Obstetrics and Gynecology Hospital of Fudan University · ORCID：0000-0002-7994-2257

发表论文 88 篇 · 总被引 2396 次 · h-index 23

代表论文

• Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study (2024 · Nature Communications · 被引 26)
• Identifying Potential Vulnerability to Long COVID Through Global‐to‐Local Inequalities in Years Lived With Disability Attributed to COVID‐19, 2020–2021, Across 920 Locations (2025 · Med Research · 被引 12)
• Association between motoric cognitive risk syndrome and future falls among Chinese community‐dwelling elderly: A nationwide cohort study (2023 · Brain and Behavior · 被引 11)
• Efficacy of Pyrotinib With/Without Trastuzumab in Treatment-Refractory, HER2-Positive Metastatic Colorectal Cancer: Result From a Prospective Observational Study (2023 · Clinical Colorectal Cancer · 被引 10)
• Development and validation of a machine learning-based clinical prediction model for monitoring liver injury in patients with pan-cancer receiving immunotherapy (2025 · International Journal of Medical Informatics · 被引 9)
• Clinical characteristics and prognosis of liver injury induced by immune checkpoint inhibitors in patients with malignancies: A real‐world retrospective study (2024 · British Journal of Clinical Pharmacology · 被引 8)